These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 16439401)

  • 21. Public injection settings in Vancouver: physical environment, social context and risk.
    Small W; Rhodes T; Wood E; Kerr T
    Int J Drug Policy; 2007 Jan; 18(1):27-36. PubMed ID: 17689341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Condom use among injection drug users accessing a supervised injecting facility.
    Marshall BD; Wood E; Zhang R; Tyndall MW; Montaner JS; Kerr T
    Sex Transm Infect; 2009 Apr; 85(2):121-6. PubMed ID: 18812391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Injecting-related injury and disease among clients of a supervised injecting facility.
    Salmon AM; Dwyer R; Jauncey M; van Beek I; Topp L; Maher L
    Drug Alcohol Depend; 2009 Apr; 101(1-2):132-6. PubMed ID: 19167171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential uptake and correlates of willingness to use a supervised smoking facility for noninjection illicit drug use.
    Collins CL; Kerr T; Kuyper LM; Li K; Tyndall MW; Marsh DC; Montaner JS; Wood E
    J Urban Health; 2005 Jun; 82(2):276-84. PubMed ID: 15872188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A cost-benefit and cost-effectiveness analysis of Vancouver's supervised injection facility.
    Andresen MA; Boyd N
    Int J Drug Policy; 2010 Jan; 21(1):70-6. PubMed ID: 19423324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of a medically supervised injection facility among street youth.
    Hadland SE; DeBeck K; Kerr T; Nguyen P; Simo A; Montaner JS; Wood E
    J Adolesc Health; 2014 Nov; 55(5):684-9. PubMed ID: 24925493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential role of safer injection facilities in reducing HIV and hepatitis C infections and overdose mortality in the United States.
    Semaan S; Fleming P; Worrell C; Stolp H; Baack B; Miller M
    Drug Alcohol Depend; 2011 Nov; 118(2-3):100-10. PubMed ID: 21515001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Accessing care for injection-related infections through a medically supervised injecting facility: a qualitative study.
    Small W; Wood E; Lloyd-Smith E; Tyndall M; Kerr T
    Drug Alcohol Depend; 2008 Nov; 98(1-2):159-62. PubMed ID: 18650034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of a supervised injecting facility on ambulance call-outs in Sydney, Australia.
    Salmon AM; van Beek I; Amin J; Kaldor J; Maher L
    Addiction; 2010 Apr; 105(4):676-83. PubMed ID: 20148794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An integrated supervised injecting program within a care facility for HIV-positive individuals: a qualitative evaluation.
    Krüsi A; Small W; Wood E; Kerr T
    AIDS Care; 2009 May; 21(5):638-44. PubMed ID: 19444673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver.
    Spittal PM; Craib KJ; Wood E; Laliberté N; Li K; Tyndall MW; O'Shaughnessy MV; Schechter MT
    CMAJ; 2002 Apr; 166(7):894-9. PubMed ID: 11949985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Supervised injection services: what has been demonstrated? A systematic literature review.
    Potier C; Laprévote V; Dubois-Arber F; Cottencin O; Rolland B
    Drug Alcohol Depend; 2014 Dec; 145():48-68. PubMed ID: 25456324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Using drugs in un/safe spaces: Impact of perceived illegality on an underground supervised injecting facility in the United States.
    Davidson PJ; Lopez AM; Kral AH
    Int J Drug Policy; 2018 Mar; 53():37-44. PubMed ID: 29278831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Employment among users of a medically supervised safer injection facility.
    Richardson L; Wood E; Zhang R; Montaner J; Tyndall M; Kerr T
    Am J Drug Alcohol Abuse; 2008; 34(5):519-25. PubMed ID: 18821450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of a fentanyl drug checking service for clients of a supervised injection facility, Vancouver, Canada.
    Karamouzian M; Dohoo C; Forsting S; McNeil R; Kerr T; Lysyshyn M
    Harm Reduct J; 2018 Sep; 15(1):46. PubMed ID: 30200991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Timing of income assistance payment and overdose patterns at a Canadian supervised injection facility.
    Zlotorzynska M; Milloy MJ; Richardson L; Nguyen P; Montaner JS; Wood E; Kerr T
    Int J Drug Policy; 2014 Jul; 25(4):736-9. PubMed ID: 24795288
    [No Abstract]   [Full Text] [Related]  

  • 37. Seeking refuge from violence in street-based drug scenes: women's experiences in North America's first supervised injection facility.
    Fairbairn N; Small W; Shannon K; Wood E; Kerr T
    Soc Sci Med; 2008 Sep; 67(5):817-23. PubMed ID: 18562065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changing risk and presentation of overdose associated with consumption of street drugs at a supervised injection site in Vancouver, Canada.
    Notta D; Black B; Chu T; Joe R; Lysyshyn M
    Drug Alcohol Depend; 2019 Mar; 196():46-50. PubMed ID: 30665151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors associated with public injecting among users of Vancouver's supervised injection facility.
    McKnight I; Maas B; Wood E; Tyndall MW; Small W; Lai C; Montaner JS; Kerr T
    Am J Drug Alcohol Abuse; 2007; 33(2):319-25. PubMed ID: 17497555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adapting harm reduction services during COVID-19: lessons from the supervised injecting facilities in Australia.
    Roxburgh A; Jauncey M; Day C; Bartlett M; Cogger S; Dietze P; Nielsen S; Latimer J; Clark N
    Harm Reduct J; 2021 Feb; 18(1):20. PubMed ID: 33596940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.